Furthermore, screening for heart failure in asymptomatic patients can help in replacing diabetes medications that increase the risk of heart failure with diabetes medications such as SGLT2 inhibitors, which are known to improve heart failure outcomes. Here, SLC5A2 is linked to heart failure.